Free Trial

Cidara Therapeutics (CDTX) Insider Trading & Ownership

Cidara Therapeutics logo
$23.22 +0.71 (+3.15%)
(As of 12/20/2024 05:16 PM ET)

Cidara Therapeutics (NASDAQ:CDTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.64%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$105,680.00
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$51,223.36
Get CDTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cidara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CDTX Insider Buying and Selling by Quarter

Cidara Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/11/2024Taylor SandisonInsiderSell924$11.64$10,755.36  
6/7/2024Jeffrey SteinCEOBuy8,000$13.21$105,680.00  
3/11/2024Leslie TariInsiderSell1,051$13.40$14,083.40  
3/11/2024Preetam ShahCFOSell946$13.40$12,676.40  
3/11/2024Shane WardCOOSell1,023$13.40$13,708.20  
(Data available from 1/1/2013 forward)

CDTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Cidara Therapeutics includes Brady Johnson, Jeffrey Stein, Leslie Tari, Paul Daruwala, Preetam Shah, Shane Ward, and Taylor Sandison. Learn more on insiders at CDTX.

7.64% of Cidara Therapeutics stock is owned by insiders. Learn more on CDTX's insider holdings.

The following insiders have purchased CDTX shares in the last 24 months: Jeffrey Stein ($205,680.00), and Leslie Tari ($9,700.00).

Insiders have purchased a total of 13,500 CDTX shares in the last 24 months for a total of $215,380.00 bought.

The following insiders have sold CDTX shares in the last 24 months: Leslie Tari ($57,347.20), Preetam Shah ($22,835.60), Shane Ward ($20,317.80), and Taylor Sandison ($10,755.36).

Insiders have sold a total of 6,383 Cidara Therapeutics shares in the last 24 months for a total of $111,255.96 sold.

Cidara Therapeutics Key Executives

  • Dr. Jeffrey L. Stein Ph.D. (Age 69)
    President, CEO & Executive Director
    Compensation: $603.7k
  • Mr. Shane M. Ward (Age 49)
    Chief Legal Officer,Corporate Secretary & COO
    Compensation: $464.54k
  • Dr. Taylor Sandison M.D. (Age 52)
    M.P.H., Chief Medical Officer
    Compensation: $497k
  • Dr. Kevin M. Forrest Ph.D. (Age 47)
    Founder and Chief Strategy Officer
    Compensation: $333.31k
  • Dr. Preetam Shah M.B.A. (Age 51)
    Ph.D., CFO, Chief Business Officer & Principal Accounting Officer
    Compensation: $577.85k
  • Ms. Allison Lewis CCP
    SPHR, Senior Vice President of People & Culture
  • Dr. Leslie Tari Ph.D. (Age 56)
    Chief Scientific Officer
    Compensation: $845.1k
  • Ms. Laura A. Navalta
    Senior Vice President of Clinical Operations
  • Dr. Nicole Davarpanah J.D.
    M.D., Senior VP of Translational Research & Development


This page (NASDAQ:CDTX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners